Try our Advanced Search for more refined results
April 02, 2012
TEVA PHARMACEUTICALS USA, INC. et al v. SEBELIUS et al
Case Number:
1:12-cv-00512
Court:
Nature of Suit:
Judge:
Firms
Companies
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 04, 2012
Teva, Cephalon Sue FDA Over Generic Provigil Exclusivity
Teva Pharmaceuticals USA Inc. and Cephalon Inc. sued the U.S. Food and Drug Administration in Washington federal court Tuesday seeking to bar the agency from robbing Teva of the marketing exclusivity period they say it earned through patent certifications for its generic version of Cephalon's blockbuster sleep disorder drug Provigil.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login